APA (7th ed.) Citation

Sonneveld, P., Goldschmidt, H., Rosiñol, L., Bladé, J., Lahuerta, J. J., Cavo, M., . . . Moreau, P. (2013). Bortezomib-based versus nonbortezomib-based induction treatment before autologous stem-cell transplantation in patients with previously untreated multiple myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials. Journal of clinical oncology, 31(26), . https://doi.org/10.1200/JCO.2012.48.4626

Chicago Style (17th ed.) Citation

Sonneveld, Pieter, et al. "Bortezomib-based Versus Nonbortezomib-based Induction Treatment Before Autologous Stem-cell Transplantation in Patients with Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials." Journal of Clinical Oncology 31, no. 26 (2013). https://doi.org/10.1200/JCO.2012.48.4626.

MLA (9th ed.) Citation

Sonneveld, Pieter, et al. "Bortezomib-based Versus Nonbortezomib-based Induction Treatment Before Autologous Stem-cell Transplantation in Patients with Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials." Journal of Clinical Oncology, vol. 31, no. 26, 2013, https://doi.org/10.1200/JCO.2012.48.4626.